JPI Healthcare Co., Ltd.
KKRX:0010V07,560.00
KRW
-160.00
(-2.07%)
ISIN
KR70010V0005
Return %
Stock
S&P 500
1Y
-61.13
14.20
3Y
- -
81.12
5Y
- -
68.34
Capital Structure
KRW
•
in mil. unless spec.Working Capital
KRW
•
in mil. unless spec.Growth Rates
KRW
•
in mil. unless spec.Quarterly Revenue
KRW
•
in mil. unless spec.Quarterly Earnings Per Share
KRW
•
in mil. unless spec.Quarterly Dividends Per Share
KRW
•
in mil. unless spec.Company Description
- CEO
- Jin-Guk Kim
- Full Time Employees
- 143
- Sector
- Health technology
- Industry
- Medical specialties
- Address
- Seoul South Korea
- IPO Date
- Aug 21, 2025
- Website
- jpi.co.kr
- Similar Companies
- Business
- JPI Healthcare Co., Ltd. is a South Korea-based medical device manufacturer primarily engaged in the development, production, and distribution of diagnostic X-ray imaging components, digital radiography systems, and clinical imaging software. Founded in 1980 and headquartered in Seoul, South Korea, the company operates within the healthcare equipment and supplies sector, supplying major global medical device original equipment manufacturers (OEMs), hospitals, diagnostic imaging centers, dental clinics, and veterinary facilities across North America, Europe, Asia-Pacific, Latin America, and the Middle East through an extensive international network that includes its subsidiary, JPI America, Inc. The company structures its operations across three primary business segments: X-Ray Components, Diagnostic Imaging Systems, and Healthcare Software Solutions. Its product and service offerings comprise anti-scatter X-ray grids, including stationary grids, mammography grids, circular grids, and specialized bucky mechanisms; digital radiography (DR) flat panel detectors, consisting of wired and wireless cesium iodide and gadolinium oxysulfide detectors for human and veterinary applications; specialized 3D cone-beam computed tomography (CBCT) systems, designed for dental, maxillofacial, ear-nose-throat (ENT), and extremity diagnostic imaging; veterinary X-ray imaging systems and digital retrofits; and proprietary software platforms, encompassing digital radiography acquisition software, diagnostic Picture Archiving and Communication System (PACS) viewers, and advanced image enhancement algorithms. In recent operational and strategic developments, JPI Healthcare Co., Ltd. has expanded its core offerings and market reach through focused research and development, product line additions, and global partnership initiatives. The company has introduced artificial intelligence-driven image processing software designed to optimize image clarity, reduce radiation scatter, and lower patient exposure doses during radiography procedures. It has also expanded its line of lightweight wireless flat panel detectors and advanced its next-generation carbon-fiber anti-scatter grid technologies to support high-throughput clinical workflows. Furthermore, JPI Healthcare has broadened its international commercial partnerships and OEM supply contracts across North America and Europe, while upgrading its manufacturing facilities and compliance systems to align with rigorous international medical device regulatory standards, including European Medical Device Regulation (MDR) certifications and U.S. FDA clearances.